NASDAQ$PETS

PetMed Express · Q4 2023 earnings

Q4 2023 earnings · · Investor relations

Briefing

Announced Q4 and fiscal year end financial results and declared a quarterly dividend of $0.30 per share.

PetMed Express reported a decrease in net sales for the quarter ended March 31, 2023, with $62.4 million compared to $66.0 million in the prior year. The company experienced a net loss of $(5.1) million, or $(0.25) diluted earnings per share, compared to a net income of $6.1 million, or $0.30 diluted earnings per share, for the prior year quarter. New customers increased by 12% year over year.

  • Net sales decreased by 5.4% compared to the fourth quarter of the prior year.
  • New customers increased 12% year over year.
  • Net loss was $(5.1) million, or $(0.25) diluted earnings per share.
  • Adjusted EBITDA was $3.6 million, a decrease of 61.8%.

Headline financials

Total Revenue

$62.4M

Previous: $66M-5.4%
EPS (adj)

$0.04

Previous: $0.30-86.7%
Capital Expenditures

$1.93M

Previous: $486K+297.3%
Free Cash Flow

$7.79M

Previous: $8.23M-5.3%
Net Income

-$5.1M

Previous: $6.1M-183.6%
Operating Income

-$7.11M

Previous: $8.46M-184.1%
Gross Profit

$17.4M

Previous: $20.9M-16.7%
Cash & Equivalents

$104M

Previous: $48.9M+113.0%
Total Assets

$164M

Previous: $180M-8.7%
Stock-Based Comp

$1.63M

Previous: $1.51M+8.0%

Revenue & EPS history

PetMed Express · Revenue · Quarterly

$62.4M

Q4 2023-5.4%vs Q4 2022
Beat estimate in 3 of 14 quarters(21%)
ActualEstimate

Forward guidance

PetMeds is focused on growth strategy, expanding product catalog, building recurring revenue, growing customer base, and adding differentiated services through partnerships. The company is confident that this process will begin to bear fruit as each component achieves scale.

Tailwinds

  • Strengthened the team
  • Enhanced our systems
  • Identified PetCareRx as a strategic acquisition opportunity
  • Turned our focus to incorporating our newly added investments
  • AutoShip & Save recurring revenue is the highest it's ever been at 44%

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q4 2023

Historical avgQ4 2023

-0.0%

Avg return

Earnings day

-1.6%

Avg return

5 days after

-0.4%

Avg return

30 days after

42%

27 / 65 earnings

Positive

+40.8%

Q2 2020

Best reaction

-26.4%

Q2 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2026-16.4%-21.1%
Q3 2026-3.6%-8.7%-15.5%
Q4 2025+0.0%-4.9%-6.6%
Q2 2026-1.4%-2.7%-8.2%
Q1 2026-1.1%-1.4%-6.9%
Q3 2025-14.8%-20.1%-22.7%
Q2 2025+34.5%+27.2%+35.0%
Q1 2025-11.0%-13.0%-4.5%
Q4 2024-0.7%-1.7%-7.4%
Q3 2024+0.2%-1.2%+8.9%
Q2 2024-26.4%-23.0%-22.6%
Q1 2024-2.8%-6.4%-20.0%
Q4 2023+6.7%+1.0%-6.6%
Q3 2023-11.1%-13.3%-19.6%
Q2 2023-10.5%-4.7%-15.5%
Q1 2023+4.3%+4.2%+0.9%
Q4 2022+6.9%+2.0%+3.0%
Q3 2022+7.2%+7.7%+3.4%
Q2 2022+5.1%+5.1%+5.2%
Q1 2022+7.1%+13.0%+3.2%
Q4 2021+2.8%+0.5%+56.5%
Q3 2021-14.3%-11.1%+3.2%
Q2 2021-2.2%-3.5%-1.9%
Q1 2021-16.0%-23.8%-17.4%
Q4 2020+3.6%-4.0%-7.5%
Q3 2020-11.0%-11.2%+4.0%
Q2 2020+40.8%+32.8%+21.7%
Q1 2020+2.5%-1.5%+5.1%
Q4 2019-9.0%-9.7%-18.9%
Q3 2019-6.2%-3.4%-3.1%
Q2 2019+2.6%+1.1%-9.7%
Q1 2019-13.0%-11.8%-6.4%
Q4 2018-0.9%+1.4%+15.1%
Q3 2018-4.8%-10.2%-12.0%
Q2 2018+4.4%-5.0%+9.0%
Q1 2018+18.6%+19.3%-10.7%
Q4 2017+34.7%+41.2%+48.4%
Q3 2017-5.1%-5.4%-3.6%
Q2 2017-3.2%-4.0%+6.6%
Q1 2017+6.0%+5.8%+3.3%
Q4 2016+2.9%
Q3 2016-4.8%
Q2 2016+2.1%
Q1 2016+0.5%
Q4 2015+2.6%
Q3 2015+14.3%
Q2 2015-3.7%
Q1 2015+5.0%
Q4 2014+1.6%
Q3 2014-12.0%
Q2 2014-10.3%
Q1 2014+12.7%
Q4 2013-0.5%
Q3 2013+7.0%
Q2 2013+6.9%
Q1 2013-16.3%
Q4 2012-5.4%
Q4 2010-5.4%
Q3 2011-0.2%
Q3 2012-0.2%
Q2 2012-0.8%
Q2 2011-0.8%
Q1 2012-0.1%
Q1 2011-0.1%
Q4 2011-0.1%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro